An Overview of the Role of Iron in T Cell Activation

Journal of Trace Elements in Experimental Medicine

Volumn 16, Issue 4, 2003, Pages 219-225

  Kuvibidila, Solo ^a   Warrier, Raj P ^b   Baliga, B Surendra ^c  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

Author keywords

CD28; CD3; CD80; Iron deficiency; Mice; Protein kinase C; T cells

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD3 ANTIGEN; DEFEROXAMINE; INTERLEUKIN 2; IRON; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; PROTEIN KINASE C;

CONFERENCE PAPER; HUMAN; IMMUNOREACTIVITY; IRON DEFICIENCY; IRON METABOLISM; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

MURINAE;

EID: 0242442183     PISSN: 0896548X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jtra.10047     Document Type: Conference Paper

References (16)

1. Walter T, Olivares M, Pizzaro F, Munoz C. Iron, anemia, and infection. Nutr Rev 1997;55:111-124.
2. Furukawa T, Naitoh Y, Kohno H, Tokunaga R, Taketani S. Iron deprivation decreases ribonucleotide reductase and DNA synthesis. Life Sci 1992;50:2059-2065.
3. Kuvibidila S, Baliga SB. Role of iron in immunity and infection. In: Calder PC, Fields CJ, Gill HS, editors. Nutrition and immune function. London: CABI Publishing, CAB International, Wallingforf, UK New York; 2002. p 209-228.
4. Smith AW, Hendricke RG, Harrison C, Hayes RJ, Greenwood BM. The effects on malaria of treatment of iron-deficiency anaemia with oral iron in Gambian children. Annals Trop Paediatr 1989;9:17-23.
5. Ferguson BJ, Skikne BS, Simpson KM, Baynes RD, Cook JD. Serum transferrin receptor distinguishes the anemia of chronic disease from iron deficiency. J Lab Clin Med 1992; 19:385-390.
6. Abbas AK, Litchman AH, Pober JS, editors. T lymphocyte antigen recognition and activation. In: Cellular and molecular immunology. Philadelphia: WB Saunders Company; 1997. p 138-170.
7. Kuvibidila SR, Baliga BS, Warrier RP, Suskind RM. Iron deficiency reduces the hydrolysis of cell membrane phosphatidyl-inositol 4,5 bis-phosphate during splenic lymphocyte activation in C57BL/6 mice. J Nutr 1998;128:1077-1083.
8. Kuvibidila SR, Kitchens D, Baliga BS. In vivo and in vitro iron deficiency reduces protein kinase C activity and translocation in murine splenic and purified T cells. J Cell Biochem 1999;74:468-478.
9. Alcantara O, Obeid L, Hannun Y, Ponka P, Boldt DH. Regulation of protein kinase C (PKC) expression by iron: Effect of different iron compounds on PKC- and PKC-gene expression and the role of the 5′ flanking region of the PKC-gene in the response to ferric transferrin. Blood 1994;84:3510-3517.
10. Phillips JL, Boldt DH, Harper J. Iron-transferrin-induced increase in protein kinase C activity in CCRF-CEM cells. J Cell Physiol 1987;132:349-353.
11. June CH, Bluestone JA, Nadler LM, Thompson CB. The B7 and CD28 receptor families. Immunol Today 1994;15:321-331.
12. Kuvibidila SR, Porretta C. Iron deficiency and in vitro iron chelation reduce the expression of CD28 but not CD3 receptors on murine thymocytes and spleen cells. Br J Nutr 2003; 90:179-189.
13. Kuvibidila SR, Porretta C. Differential effects of iron deficiency on the expression of CD80 and CD86 co-stimulatory receptors in mitogen-treated and untreated murine spleen cells. J Cell Biochem 2002;86:571-582.
14. Kuvibidila SR, Velez M, Yu L, Warrier RP, Baliga BS. Differences in iron requirements by concanavalin A-treated and anti-CD3-treated murine splenic lymphocytes. Br J Nutr 2002; 88:67-72.
15. Kuvibidila SR, Porretta C, Baliga BR. Iron deficiency alters the progression of mitogen-treated murine splenic lymphocyte through the cell cycle. J Nutr 2001;131:2028-2033.
16. cdk2 kinase. Blood 1995;86:2268-2280.